Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Voss

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Journal of Clinical Medicine|January 21, 2022
Therapeutic Anticoagulation Impacts MR Morphologic Recurrence Patterns in Glioblastoma-A Matched-Pair AnalysisDaniel Dubinski, Sae-Yeon Won, Bedjan Behmanesh, et al.
BMC Research Notes|May 15, 2024
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based studyLisa Falchetto, Bernd Bender, Ian Erhard, et al.
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
European Journal of Nutrition|September 6, 2021
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trialMartin Voss, Katharina J Wenger, Nina von Mettenheim, et al.
Frontiers in Immunology|February 11, 2020
ADAP Promotes Degranulation and Migration of NK Cells Primed During <i>in vivo Listeria monocytogenes</i> Infection in MiceMartha A L Böning, Stephanie Trittel, Peggy Riese, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal of Neurosurgery|February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaHendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Journal of Clinical Medicine|January 21, 2022
Therapeutic Anticoagulation Impacts MR Morphologic Recurrence Patterns in Glioblastoma-A Matched-Pair AnalysisDaniel Dubinski, Sae-Yeon Won, Bedjan Behmanesh, et al.
BMC Research Notes|May 15, 2024
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based studyLisa Falchetto, Bernd Bender, Ian Erhard, et al.
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
European Journal of Nutrition|September 6, 2021
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trialMartin Voss, Katharina J Wenger, Nina von Mettenheim, et al.
Frontiers in Immunology|February 11, 2020
ADAP Promotes Degranulation and Migration of NK Cells Primed During <i>in vivo Listeria monocytogenes</i> Infection in MiceMartha A L Böning, Stephanie Trittel, Peggy Riese, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal of Neurosurgery|February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaHendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Pageof 11